Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — A study showed Bimatoprost sustained-release implant was noninferior to timolol and may ...

September 3, 2010 — The US Food and Drug Administration (FDA) has approved bimatoprost 0.01% ophthalmic solution (Lumigan; Allergan) for the first-line treatment of elevated intraocular pressure (IOP) ...

The aim of this study was to determine whether a switch to bimatoprost 0.03% monotherapy in nonresponding patients with glaucoma or ocular hypertension provides additional intraocular pressure (IOP) ...

Learn everything you need to know about Bimatoprost-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

Review the side-effects of Bimatoprost as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Eye drops used to treat glaucoma hold the key to a cure for baldness. Researchers have found bimatoprost, a key ingredient in the Lumigan drug, increases hair growth. The drug is given as eye drops to ...

- DURYSTA™ lowered intraocular pressure in patients with open-angle glaucoma or ocular hypertension by approximately 30 percent from baseline in two Phase 3 studies - - Allergan continues five ongoing ...

Many people schedule eye exams expecting a quick vision check and a new prescription. The surprise comes when an optometrist ...